Related Experiment Video
Updated: Jan 7, 2026

Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
Published on: October 25, 2024
Pathological Characteristics of Aspirated Thrombi From Coronary Artery Embolism in Patients With Acute Myocardial
Takao Konishi1,2, Naohiro Funayama3, Daisuke Sunaga3
1Department of Cardiology, National Defense Medical College, Tokorozawa, JPN.
Insights
Thrombi from acute myocardial infarction due to coronary artery embolism are richer in erythrocytes and fresher than those from atherosclerotic causes. Identifying the cause of myocardial infarction is crucial for effective anticoagulation therapy.
Area of Science:
- Cardiology
- Pathology
- Biomedical Research
Background:
- Pathological differences in thrombi between atherosclerotic causes and coronary artery embolism (CE) in acute myocardial infarction (AMI) are not well understood.
- Understanding these differences is key for appropriate treatment strategies.
Purpose of the Study:
- To compare the pathological features of aspirated thrombi in AMI patients with CE versus those with atherosclerotic causes (non-CE).
Main Methods:
- Analysis of coronary thrombi from 89 AMI patients (4 CE, 85 non-CE) between 2015-2019.
- Histopathological assessment using H&E and elastica-Masson staining.
- Immunohistochemistry for CD34 (endothelial cells) and CD68 (macrophages).
Main Results:
- Patients with CE had higher rates of atrial fibrillation (100% vs. 9%).
- Thrombi in CE patients were significantly more erythrocyte-dominant (55.6% vs. 12.6%) and fresher (75% fresh vs. 18%).
Conclusions:
- AMI due to CE involves thrombi that are more erythrocyte-dominant and fresher compared to atherosclerotic causes.
- Distinguishing the etiology of AMI is vital for implementing targeted anticoagulation therapy for secondary prevention in CE patients.
Background:
The pathological differences in aspirated thrombi between atherosclerotic causes and coronary artery embolism (CE) in patients with acute myocardial infarction (AMI) remain poorly understood. The purpose of this study was to compare the pathological features of aspirated thrombi between AMI patients with CE and those with atherosclerotic causes (non-CE). Methods: We analyzed coronary thrombi retrieved between 2015 and 2019 from 89 consecutive patients presenting with de novo AMI, of whom four had CE and 85 did not. CE was diagnosed based on angiographic and other diagnostic imaging findings. The samples were stained with hematoxylin and eosin (H&E) and elastica-Masson stain (EM). Immunohistochemistry was performed using specific antibodies against CD34 and CD68 to detect endothelial cells and macrophages, respectively. The aspirated thrombi were assessed for their histopathological characteristics.
Results:
Atrial fibrillation (AF) was more frequently documented in patients with CE than in those with non-CE (100% vs. 9%). The erythrocytes and erythrocytes/total thrombus areas were greater. The prevalence of erythrocyte-dominant thrombi was significantly higher in patients with CE than in those with non-CE (4.94 mm² (3.38-7.35 mm²) vs. 0.62 mm² (0.05-2.51 mm²); 55.6% (50.9-57.7%) vs. 12.6% (2.0-36.2%), P = 0.002; and 75% vs. 7%, P = 0.003, respectively). The age of aspirated thrombi was significantly fresher in CE than in the non-CE ("fresh": 75% vs. 18%, "lytic": 25% vs. 28%, and "old": 0% vs. 54%, respectively).
Conclusions:
This study suggests that aspirated thrombi derived from patients with AMI due to CE are more erythrocyte-dominant and fresher than those derived from patients with AMI due to atherosclerotic causes. Identifying the etiology of patients with AMI is important because anticoagulation therapy is essential for secondary prevention in patients with CE.
More Related Videos
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism I: Introduction
Venous Thrombosis I: Introduction
Coronary Artery Disease II: Pathophysiology

